Mobile Messaging Intervention to Present New HIV Prevention Options for Men Who Have Sex With Men (MSM)

Completed · Not applicable

Conditions studied: Human Immunodeficiency Virus

In brief

The study will evaluate the use and effectiveness of mobile-messaging platforms as a public health strategy for improving sexual health outcome measures among men who have sex with men (MSM) by determining whether exposure to the message-delivery platform results in improvements in participants' self-reported sexual health and prevention behaviors, beliefs and attitudes. The study will enroll men into a randomized controlled trial. Participants randomized to the messaging intervention will have access to a smartphone-based messaging platform for three months while those assigned to the waitlist group will be offered access to the messaging platform after all follow up is complete. Participants will complete surveys at baseline, after the end of the 3 month intervention, and follow up surveys 6 and 9 months after the baseline survey.

Key facts

Study ID

NCT03666247

Run by

Emory University

People needed

1229

Starts

2018-01-24

Expected to finish

2019-12-18

Last updated by the study team

2020-01-06

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Assigned male at birth
• Current, self-reported gender identity as "Male"
• Aged 18 or over
• Self-reported ability to read and understand English-language
• Resides in the Atlanta, Georgia (GA), New York, New York (NY), or Detroit, Michigan (MI) Metropolitan Statistical Area.
• Self-reported anal sex with a male partner in the past 12 months
• Owns and uses an Android or Apple (iOS) smartphone
• Is included in one of the following risk groups, by self-report:
• HIV seropositive
• HIV seronegative at "higher risk" (condomless anal sex and not taking PrEP as prescribed in the past 3 months)
• HIV seronegative at "lower risk" (no condomless anal sex in the past 3 months, or condomless and sex while taking PrEP as prescribed in the past 3 months)

You may not qualify if…

• Currently participating in another HIV prevention research study or program
• Participant's phone or device does not support HealthMindr application
• Tested positive for HIV for the first time in the past 6 months
• Has a plan to move out of the Atlanta, GA, New York, NY or Detroit, MI, Metropolitan Statistical Area within in the next 9 months

Where it is running

• Emory University — Atlanta, Georgia, United States
• University of Michigan — Detroit, Michigan, United States
• Emory University — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.